Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 19, 2019
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
[ Fri, Jul 19th 2019
] - WOPRAI
Thu, July 18, 2019
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
[ Thu, Jul 18th 2019
] - WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Increased Target to $93 on, Jul 18th, 2019
Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $87 to $93 on, Jul 18th, 2019.
Jayson has made no other calls on ABT in the last 4 months.
There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, 0 agree with Jayson's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jayson
- David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $93 on, Tuesday, July 16th, 2019
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $91 on, Thursday, June 13th, 2019
Similar Stocks and Investing Articles
[ Wed, Jan 02nd 2019
] - WOPRAI
[ Wed, Jan 02nd 2019
] - WOPRAI
[ Wed, Jan 02nd 2019
] - WOPRAI
[ Tue, Dec 18th 2018
] - WOPRAI
[ Tue, Dec 04th 2018
] - WOPRAI
[ Fri, Nov 30th 2018
] - WOPRAI
[ Tue, Nov 13th 2018
] - WOPRAI
[ Thu, Oct 18th 2018
] - WOPRAI
[ Tue, Oct 16th 2018
] - WOPRAI
[ Thu, Oct 11th 2018
] - WOPRAI